Acetylglucosamine: Clinical Trials

7 trials of Acetylglucosamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 not yet recruiting, 1 terminated. 3 Phase 2, 2 Phase 1, 2 Phase 3, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Not yet recruiting 1, Unknown 1
Phase 12Completed 1, Terminated 1
Phase 32Unknown 2
Not applicable1Completed 1

Follow Acetylglucosamine: new trials by email Literature Review of Acetylglucosamine trials Research Report on Acetylglucosamine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral N-acetylglucosamine in Crohn's Disease
N-Acetylglucosamine (GlcNAc) - Crohns Disease
Phase 2Not yet recruitingJohns Hopkins University402027-01-052026-11-05
Effect of Hyaluronic Acid Oral Supplementation on Sexual and Urinary Symptoms of Women With Recurrent Urinary Tract Infections
HA 100 mg, CS 400 mg, N-Acetylglucosamine 200 mg and vitamin C 80 mg + cranberry, D-mannose, propolis extract, tumeric and Boswellia, cranberry, D-mannose, propolis extract, tumeric and Boswellia - Urinary Tract Infections, Recurrent
Not applicableCompletedFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico502022-03-012024-02-20
N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)
N-acetyl glucosamine (NAG), Control - Coronavirus, Covid19
Phase 1CompletedQuantinosis.ai LLC1502020-11-142023-04-04
Therapeutic Approaches to Malnutrition Enteropathy
Colostrum high protein powder (Neovite), N-Acetyl Glucosamine (GInNAC), Teduglutide - Severe Acute Malnutrition
Phase 2CompletedQueen Mary University of London1252020-05-042021-09-27
Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation
N-Acetylglucosamine (GlcNAc), Uridine - PGM3
Phase 1TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)22015-06-302017-07-02
Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
Starch Placebo, N-acetyl-D-glucosamine - Irritable Bowel Syndrome
Phase 3UnknownThird Military Medical University7202015-06-012015-07-21
Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
N-acetyl-D-glucosamine, placebo - Irritable Bowel Syndrome
Phase 2 / Phase 3UnknownThird Military Medical University1802013-04-012015-07-24

Conditions studied

Abdominal Pain (2)  ·  Diarrhea (2)  ·  Irritable Bowel Syndrome (2)  ·  COVID-19 (1)  ·  Coronavirus Infections (1)  ·  Crohn Disease (1)  ·  Severe Acute Malnutrition (1)  ·  Urinary Tract Infections (1)

Sponsors

Third Military Medical University (2)  ·  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  Johns Hopkins University (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Quantinosis.ai LLC (1)  ·  Queen Mary University of London (1)

Countries

United States (3)  ·  China (2)  ·  Italy (1)  ·  Zambia (1)  ·  Zimbabwe (1)

Top investigators

Junkang Liu, Doctor (2)  ·  Andrew Prendergast, PhD (1)  ·  Beatrice Amadi, MD (1)  ·  Joanna Melia, MD (1)  ·  Jonathan J Lyons, M.D. (1)  ·  Mutsa Bwakura-Dangarembizi, MB (1)  ·  Paul Kelly, MD (1)

Results publications

PMID 31727642, PMID 34306677, PMID 38632262, PMID 38721680

NIH funding

R01DK141870 (1)